» Articles » PMID: 33860171

Combining Psychedelic and Mindfulness Interventions: Synergies to Inform Clinical Practice

Overview
Specialty Biochemistry
Date 2021 Apr 16
PMID 33860171
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Psychedelic and mindfulness interventions have been shown to improve mental ill-health and wellbeing, with a range of clinical processes and effects in common. However, each appear to contain specific challenges in the context of mental health treatment. In this Perspective, we focus on a set of distinct affordances, "useful differences", within psychedelic and mindfulness interventions that might address common challenges within the other intervention. Accordingly, we propose a set of applied synergies, indicating specific ways in which these two promising interventions might be combined for greater benefit. Metaphorically, on the journey toward mental health and wellbeing, we propose that psychedelic treatments may serve the role of Compass (initiating, motivating, and steering the course of mindfulness practice), with mindfulness interventions serving the role of Vehicle (integrating, deepening, generalizing, and maintaining the novel perspectives and motivation instigated by psychedelic experience). We outline a set of testable hypotheses and future research associated with the synergistic action of psychedelic and mindfulness interventions toward improved clinical outcomes.

Citing Articles

Can psychedelic use benefit meditation practice? Examining individual, psychedelic, and meditation-related factors.

Jiwani Z, Goldberg S, Stroud J, Young J, Curtin J, Dunne J PLoS One. 2025; 20(2):e0310160.

PMID: 39937729 PMC: 11819602. DOI: 10.1371/journal.pone.0310160.


Psilocybin-Assisted Group Psychotherapy + Mindfulness Based Stress Reduction (MBSR) for Frontline Healthcare Provider COVID-19 Related Depression and Burnout: A Randomized Clinical Trial.

Lewis B, Hendrick J, Byrne K, Odette M, Wu C, Garland E medRxiv. 2025; .

PMID: 39802794 PMC: 11722457. DOI: 10.1101/2024.12.31.24319806.


Strategies for resolving challenging psychedelic experiences: insights from a mixed-methods study.

Wood M, McAlpine R, Kamboj S Sci Rep. 2024; 14(1):28817.

PMID: 39572645 PMC: 11582610. DOI: 10.1038/s41598-024-79931-w.


Meditating on psychedelics. A randomized placebo-controlled study of DMT and harmine in a mindfulness retreat.

Meling D, Egger K, Aicher H, Jareno Redondo J, Mueller J, Dornbierer J J Psychopharmacol. 2024; 38(10):897-910.

PMID: 39340164 PMC: 11487865. DOI: 10.1177/02698811241282637.


Can Psychedelic Use Benefit Meditation Practice? Examining Individual, Psychedelic, and Meditation-Related Factors.

Jiwani Z, Goldberg S, Stroud J, Young J, Curtin J, Dunne J medRxiv. 2024; .

PMID: 39252913 PMC: 11383514. DOI: 10.1101/2024.08.27.24312677.


References
1.
Carhart-Harris R, Bolstridge M, Day C, Rucker J, Watts R, Erritzoe D . Psilocybin with psychological support for treatment-resistant depression: six-month follow-up. Psychopharmacology (Berl). 2017; 235(2):399-408. PMC: 5813086. DOI: 10.1007/s00213-017-4771-x. View

2.
Fredrickson B, Cohn M, Coffey K, Pek J, Finkel S . Open hearts build lives: positive emotions, induced through loving-kindness meditation, build consequential personal resources. J Pers Soc Psychol. 2008; 95(5):1045-1062. PMC: 3156028. DOI: 10.1037/a0013262. View

3.
Barrett F, Griffiths R . Classic Hallucinogens and Mystical Experiences: Phenomenology and Neural Correlates. Curr Top Behav Neurosci. 2017; 36:393-430. PMC: 6707356. DOI: 10.1007/7854_2017_474. View

4.
Johnson M, Garcia-Romeu A, Griffiths R . Long-term follow-up of psilocybin-facilitated smoking cessation. Am J Drug Alcohol Abuse. 2016; 43(1):55-60. PMC: 5641975. DOI: 10.3109/00952990.2016.1170135. View

5.
Tursi M, Baes C, Camacho F, Tofoli S, Juruena M . Effectiveness of psychoeducation for depression: a systematic review. Aust N Z J Psychiatry. 2013; 47(11):1019-31. DOI: 10.1177/0004867413491154. View